MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
securities
$30,000K
Proceeds from sale of
fixed assets
$9K
Net cash provided by
investing activities
$15,712K
Canceled cashflow
$14,297K
Net decrease in cash
and cash...
$4,568K
Canceled cashflow
$11,144K
Purchases of marketable
securities
$14,297K
Stock-based compensation
$2,136K
Other assets
-$674K
Reclassification of currency
translation loss
$282K
Depreciation and
amortization
$227K
Amortization of debt discount
and issuance costs...
$37K
Net cash used in
operating activities
-$9,830K
Net cash (used in)
provided by financing...
-$1,305K
Effect of exchange rate
changes on cash and cash...
-$9K
Canceled cashflow
$3,356K
Net loss
-$11,227K
Repayment of loan
principal
$1,305K
Operating lease assets and
liabilities
$603K
Amortization of premiums and
discounts on marketable...
$494K
Prepaid expenses and
other current assets
$432K
Accounts payable,
accrued and other...
-$426K
Gain on disposition
of fixed assets
$4K
Back
Back
Cash Flow
source: myfinsight.com
Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences, Inc. (KZR)